Radicon Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 18 Year, 1 Day
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 Cr
- Satisfied Charges ₹ 3.00 Cr
- Revenue Growth 1.49%
- Profit Growth 814.07%
- Ebitda -31.51%
- Net Worth 61.46%
- Total Assets -4.71%
About Radicon Laboratories
Radicon Laboratories Limited. (RLL) is a leading Public Limited Indian Non-Government Company incorporated in India on 01 February 2007 and has a history of 18 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.50 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Meenu Khaneja, Sagar Khaneja, and Mahima Khaneja serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232DL2007PLC158626
-
Company No.
158626
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
01 Feb 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Radicon Laboratories Limited. offer?
Radicon Laboratories Limited. offers a wide range of products and services, including Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Sexual Wellness Products, Female Hygiene Products & Test Kits, Common Disease Medicines, Pharmaceutical Capsules, Antacid Drugs, Rabeprazole Domperidone Capsule.
Who are the key members and board of directors at Radicon Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahima Khaneja
|
Director | 16-Sep-2020 | Current |
|
Meenu Khaneja
|
Director | 01-Feb-2007 | Current |
|
Sagar Khaneja
|
Director | 07-Aug-2018 | Current |
Financial Performance of Radicon Laboratories.
Radicon Laboratories Limited., for the financial year ended 2022, experienced modest growth in revenue, with a 1.49% increase. The company also saw a substantial improvement in profitability, with a 814.07% increase in profit. The company's net worth Soared by an impressive increase of 61.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Radicon Laboratories?
In 2022, Radicon Laboratories had a promoter holding of 99.80% and a public holding of 0.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ambitree India Private LimitedMeenu Khaneja is a mutual person
-
Kritajna Beauty World Private LimitedMeenu Khaneja and Mahima Khaneja are mutual person
-
Shree Gobind Pharmaceuticals Private Limited
Meenu Khaneja and Sagar Khaneja are mutual person
-
Shree Radhey Gobind Pharmaceuticals Private Limited
Meenu Khaneja and Sagar Khaneja are mutual person
Charges (Loans)
₹45.00 M
₹30.00 M
Charges Breakdown by Lending Institutions
- Others : 4.00 Cr
- Ing Vysya Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Oct 2023 | Others | ₹4.00 Cr | Open |
| 26 Dec 2013 | Ing Vysya Bank Limited | ₹5.00 M | Open |
| 24 Mar 2022 | Others | ₹3.00 Cr | Satisfied |
How Many Employees Work at Radicon Laboratories?
Radicon Laboratories has a workforce of 47 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Radicon Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Radicon Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
